Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans. The Company is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. The Company aims to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.
|HQ||Berkeley, CA, US||Map|
|Employees (est.) (Jan 2021)||8|
Fauna Bio total Funding
Fauna Bio latest funding size
Time since last funding
|2 years ago|
Fauna Bio investors
|True Ventures, Pacific 8 Ventures, The Longevity Fund, Boom Capital, Beagle Ventures|
Fauna Bio has 492 Twitter Followers. The number of followers has increased 2.7% month over month and increased 5.4% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Fauna Bio founded?
Fauna Bio was founded in 2018.
Who are Fauna Bio key executives?
Fauna Bio's key executives are Ashley Zehnder, Katie Grabek and Linda Goodman.
How many employees does Fauna Bio have?
Fauna Bio has 8 employees.
Who are Fauna Bio competitors?
Competitors of Fauna Bio include Edgewise Therapeutics, AmacaThera and CinCor Pharma.
Where is Fauna Bio headquarters?
Fauna Bio headquarters is located at Harold Way, Berkeley.
Where are Fauna Bio offices?
Fauna Bio has an office in Berkeley.
How many offices does Fauna Bio have?
Fauna Bio has 1 office.
Receive alerts for 300+ data fields across thousands of companies